Ousted Novartis scientist 'categorically denies' wrongdoing in data manipulation scandal

The revelation by the FDA earlier this month that Novartis not only relied on manipulated data in a drug's application, but did so knowingly, has put pressure on its CEO Vas Narasimhan.